Los puntos clave no están disponibles para este artículo en este momento.
Patients with MELAS carrying the m.3243A>G mutation show a measurable decline in clinical and imaging outcomes. It is hoped that these data will be helpful in anticipating the disease course and in planning clinical trials for MELAS.
Kaufmann et al. (Thu,) studied this question.